Innoviva (INVA) Amortization - Intangibles (2014 - 2026)
Innoviva's (INVA) quarterly Amortization - Intangibles came in at $6.6 million in Q1 2026, up 1.22% YoY from $6.5 million in Q1 2025, and down 66.56% on a QoQ basis from $19.6 million in Q3 2025.
Innoviva (INVA) Amortization - Intangibles (2014 - 2026) Analysis & Trends
Innoviva (INVA) has 6 years of Amortization - Intangibles data on file, last reported at $6.6 million in Q1 2026.
- Quarterly Amortization - Intangibles rose 1.22% year-over-year to $6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.1 million (up 1.09% YoY) and the FY2025 annual result came in at $26.3 million, up 1.45% from the prior year.
- Amortization - Intangibles eased to $6.6 million in Q1 2026, from $19.6 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $19.6 million in Q3 2025 to a low of $1.5 million in Q3 2022.
- A 5-year average of $8.8 million and a median of $6.5 million in 2025 frame the typical range for Amortization - Intangibles.
- Annual changes were most pronounced in 2023 — Amortization - Intangibles jumped 912.57% — and 2025, when it advanced 0.54%.
- Tracing INVA's Amortization - Intangibles over 5 years: stood at $1.5 million in 2022, then jumped by 912.57% to $15.3 million in 2023, then increased by 26.74% to $19.4 million in 2024, then advanced by 1.08% to $19.6 million in 2025, then slumped by 66.56% to $6.6 million in 2026.
- The last three Amortization - Intangibles figures came in at $6.6 million (Q1 2026), $19.6 million (Q3 2025), and $6.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.63 Mn |
| Mar 31, 2026 | 6.55 Mn |
| Sep 30, 2025 | 19.60 Mn |
| Jun 30, 2025 | 6.50 Mn |
| Mar 31, 2025 | 6.48 Mn |
| Sep 30, 2024 | 19.39 Mn |
| Jun 30, 2024 | 6.40 Mn |
| Mar 31, 2024 | 6.44 Mn |
| Sep 30, 2023 | 15.30 Mn |
| Jun 30, 2023 | 4.96 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Sep 30, 2022 | 1.51 Mn |
| Sep 30, 2014 | 3.23 Mn |